Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer Study
Clinical trial NCT07647016 · RECRUITING
Trial details
- NCT number
- NCT07647016
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-12-30
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.